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Abstract MPM-2 antigens are a large family of mitotic
phosphoproteins that contain similar phosphoepitopes recognized
by the anti-phosphoepitope antibody MPM-2 (MPM-2 epi-
topes). These proteins are phosphorylated during M phase
induction and dephosphorylated from the onset of anaphase
through interphase. Since biochemical characterization of the
MPM-2 epitope phosphatase requires a specific assay for its
activity, we tested different methods for measurement of the
MPM-2 epitope phosphatase activity in crude cell lysates. First,
an ELISA-based assay was designed that measured the
phosphatase-induced reduction of the MPM-2 reactivity in crude
M phase cell lysates. Using this assay to follow the phosphatase
activity during sequential chromatography of Xenopus oocyte
extracts, one predominant peak of phosphatase activity was
detected which was separated from the majority of PP1 and
PP2A activities. This phosphatase activity dephosphorylated the
MPM-2 epitope on multiple MPM-2 antigens. The second
method measured dephosphorylation of cdc25, a known MPM-2
antigen. Two major peaks of cdc25 dephosphorylating activities
were detected during the sequential chromatography, one that
copurified with the major peak of MPM-2 epitope phosphatase
activity, and the other with the major peak of PP2A activity.
Finally, we examined whether GST-MPM2, a fusion protein
between glutathione S-transferase and a 19-residue peptide that
contained two representative MPM-2 epitope sequences, could
be dephosphorylated efficiently and specifically by the major
MPM-2 epitope phosphatase activity in Xenopus oocyte
extracts. Neither the crude extract nor the partially purified
MPM-2 epitope phosphatase activity efficiently dephosphoryl-
ated the MPM-2 epitope on GST-MPM2. These results
demonstrate that the ELISA-based assay preferentially detects
the MPM-2 epitope phosphatase activity in crude cell lysates
which may represent a physiological MPM-2 epitope phospha-
tase.
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1. Introduction
Protein phosphorylation and dephosphorylation play im-
portant roles in controlling the entry into and exit from
mitosis in the eukaryotic cell cycle. MPM-2 antigens, pro-
teins that are recognized by the anti-phosphoepitope anti-
body MPM-2, are a large family of mitotic phosphoproteins
that are phosphorylated during M phase induction and de-
phosphorylated from the onset of anaphase through inter-
phase [1]. Because MPM-2 is a monoclonal antibody, the
MPM-2 antigens that it recognizes are expected to contain
similar phosphoepitopes which are dephosphorylated by one
or few phosphatases. The phosphoepitopes recognized by
MPM-2 (MPM-2 epitopes) contain phosphoserine or phos-
phothreonine followed by proline [2,3]. Genetic studies in
Aspergillus suggest that PP1 activity is required for the
dephosphorylation of MPM-2 antigens at the exit from
mitosis [4]. However, there has been no biochemical char-
acterization of the MPM-2 epitope phosphatase in any sys-
tem.
Since the MPM-2 epitope phosphatase is likely to be a
crucial regulator in the cell cycle, it is important to de¢ne
its molecular identity and investigate its cell cycle regulation.
One crucial step towards achieving these goals is the develop-
ment of a speci¢c assay that measures its activity in crude cell
lysates. Such an assay would allow biochemical identi¢cation
and puri¢cation of candidate phosphatases from crude cell
lysates. It would also allow measurement of the MPM-2 epi-
tope phosphatase activity in the cell cycle.
In developing a speci¢c assay that measures the MPM-2
epitope phosphatase activity in crude cell lysates, three com-
plications were considered. First, it is currently unknown
whether one or several similar phosphatases dephosphorylate
the MPM-2 epitope on MPM-2 antigens. Second, MPM-2
antigens may also contain phosphorylation sites unrelated to
the MPM-2 epitope and thus be dephosphorylated by multiple
phosphatases. Third, serine/threonine protein phosphatases
often have broad substrate speci¢cities when assayed in vitro
using puri¢ed substrates. Because of these considerations, a
phosphatase assay involving the use of a single puri¢ed
MPM-2 antigen may not be selective enough to preferentially
detect the MPM-2 epitope phosphatase activity in the pres-
ence of other phosphatase activities.
In this study, we tried three di¡erent methods for measure-
ment of the MPM-2 epitope phosphatase activity. The ¢rst
was an ELISA-based method that measures the reduction of
the MPM-2 reactivity in crude M phase lysates. The second
measures dephosphorylation of a single puri¢ed MPM-2 anti-
gen, cdc25. The third measures dephosphorylation of the
MPM-2 epitope consensus sequence in a fusion protein. Our
results demonstrate that only the ELISA-based assay is both
e⁄cient and selective for detection of the MPM-2 epitope
phosphatase activity.
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2. Materials and methods
2.1. Bu¡ers and reagents
M phase egg extraction bu¡er (EB) contained 80 mM sodium L-
glycerophosphate, 20 mM EGTA, and 15 mM MgCl2, pH 7.3 [5].
Interphase egg extraction bu¡er (XB) contained 100 mM KCl,
1 mM MgCl2, 0.1 mM CaCl2, 50 mM sucrose, and 10 mM K-HEPES
pH 7.4 [6]. The extract dilution bu¡er for the ELISA-based assay
(DB) contained 100 mM KCl, 15 mM MgCl2, 0.3 mM CaCl2, 1 mM
DTT, 50 mM sucrose and 10 mM K-HEPES, pH 7.4. Tris-based
saline-Tween 20 (TBST) contained 10 mM Tris, pH 7.5, 150 mM
NaCl, and 0.05% Tween-20. The beads washing bu¡er (WB) was
EB containing 0.5 M NaCl, 1 mM ATP, 5 mM NaF, 2 mM dithio-
threitol (DTT), and 0.5% NP-40. Okadaic acid (OA) was purchased
from LC Services Corporation (Woburn, MA) dissolved into DMSO
to make a 1 mM stock solution, and stored at 320‡C.
2.2. Preparation of Xenopus oocyte and egg extracts
Interphase-arrested Xenopus oocyte extract (IOE, 10 mg/ml) was
prepared as previously described [7], except that the oocytes were
homogenized in an equal volume of XB containing 250 mM NaCl,
5 mM DTT, and 1 Wg/ml each of the protease inhibitors including
benzamidine, aprotinin, and soybean trypsin inhibitor [8]. M phase-
arrested Xenopus egg extract (MEE, 10 mg/ml) was prepared as pre-
viously described [9], except that the eggs were homogenized in an
equal volume of EB containing 1 mM ATP, 1 WM OA, 5 mM DTT,
and the same protease inhibitors. Interphase-arrested Xenopus egg
cytosol (60 mg/ml) was prepared from unfertilized Xenopus eggs
that had been activated by incubation with calcium ionophore
A231587 in the presence of protein synthesis inhibitor, cycloheximide
[10]. All extracts were immediately stored at 370‡C.
2.3. ELISA-based assay for measurement of the MPM-2 epitope
phosphatase activity
Wells of 96-well microtiter plates (Costar, Cambridge, MA) were
individually coated with 200 Wl of MEE that was diluted 1:80 with EB
containing 1 mM ATP, 1 mM DTT, and 20 mM NaF either at 4‡C
overnight or at 37‡C for 2 h. After the coated wells were rinsed four
times with TBST, 200 Wl of each phosphatase sample in DB or DB
alone were added to two or three coated wells. The plate was then
incubated at either room temperature (RT) or 37‡C for the length of
time indicated in the text and the reaction was stopped by rinsing the
wells three times with TBST. For antibody binding, each well was ¢rst
incubated with TBST plus 10% fetal calf serum (blocking solution) at
RT for 1 h, then with 200 Wl of 1:500 diluted MPM-2 or control
ascites in the blocking solution at RT for 2 h, and ¢nally with 200
Wl of 1:5000 diluted goat anti-mouse IgG conjugated with alkaline
phosphatase (Bio-Rad Laboratories, Hercules, CA) in the blocking
solution at RT for 1 h. After each step, the wells were rinsed four
times with TBST. For development, each well was incubated with 125
Wl of 1 mg/ml p-nitrophenol phosphate (Bio-Rad Laboratories) in 1 M
diethanolamine, pH 9.3^9.5, and 5 mM MgCl2 at RT for 30 min
which was followed by addition of 75 Wl of 1 N NaOH to stop the
development. Individual wells were then measured for absorbance at
405 nm (OD405) using a Microtiter EIA reader (Bio-Rad Laborato-
ries). The readings from the duplicate or triplicate wells were averaged
and subtracted from the averaged value obtained from the control
antibody-incubated wells, which were representative of the back-
ground. The percent reduction in the MPM-2 reactivity was calculated
as (OD405 of the bu¡er treated3OD405 of the phosphatase
treated):OD405 of the bu¡er treatedU100%.
2.4. Measurement of 32P release from the substrates
Interphase-arrested Xenopus egg cytosol which contained hypo-
phosphorylated MPM-2 antigens [7] was mixed with an equal volume
of EB containing 2 WM OA and 2 WCi/Wl [Q-32P]ATP and incubated at
RT for 1 h. Incubation of the interphase egg cytosol with both EB
and OA induced phosphorylation of most if not all MPM-2 antigens
(unpublished results). The labeled cytosol was then diluted 1:250 with
EB containing 1 mM ATP, 1 mM DTT, and 2 WM OA and coated
onto microtiter plates at RT for 3 h. After the coated plate was
washed four times with TBST, 200 Wl of IOE of di¡erent dilutions
were added to three coated wells, which were then incubated at RT
for 1 h. The IOE samples were recovered and the wells washed four
times with TBST. The IOE samples and the ¢rst wash were combined
and subjected to scintillation counting. The cpms from the triplicate
wells were averaged and subtracted from the value obtained from the
control bu¡er-incubated wells, which were representative of the back-
ground. The washed wells were measured for the MPM-2 reactivity as
described above.
2.5. Immunoblotting
Proteins were separated by 12.5% SDS-PAGE and electrophoreti-
cally transferred onto nitrocellulose membrane. Immunoblotting was
performed as previously described [9]. MPM-2 ascites was produced
as previously described [1] and used upon 1:500 dilution. The anti-
human PP1 or PP2A antibody was purchased from Upstate Biotech-
nology, Inc. (UBI, Lake Placid, NY) and used at 1 Wg/ml. The alka-
line phosphatase-conjugated goat anti-mouse or rabbit IgG was pur-
chased from Promega Corporation (Madison, WI) and used at
1:15 000 dilution.
2.6. Chromatography of Xenopus oocyte extracts
Ammonium sulfate precipitation was done by incubation of the
samples at 4‡C for 30 min followed by centrifugation at 35 000Ug
at 4‡C for 30 min. The ammonium sulfate-precipitated proteins were
desalted through gel ¢ltration with an Econo Pac 10 DG desalting
column (Bio-Rad Laboratories). All chromatographies were per-
formed at 4‡C in DB unless otherwise indicated. For each sequential
chromatography, 5 ml of IOE was precipitated with 45% ammonium
sulfate and then desalted into DB. The desalted sample was applied to
a 5 ml HiTrap Q-Sepharose column (Pharmacia Biotech Inc., Piscat-
away, NJ), which was then washed with 15 ml DB and sequentially
eluted with 15 ml DB containing 0.2 M NaCl and 1.0 M NaCl. The
0.2 M NaCl eluate was concentrated by ammonium sulfate precipita-
tion (45%) and desalted into 0.25UDB. The desalted sample was
applied to a 5 ml HiTrap heparin-Sepharose column (Pharmacia Bio-
tech Inc.), which was then washed with 15 ml of 0.25UDB and se-
quentially eluted with 15 ml of 0.25UDB containing 0.09 M NaCl
and 1.0 M NaCl. The 0.09 M NaCl eluate was concentrated by am-
monium sulfate precipitation (60%) and was further fractionated by
FPLC on a Superose 6 gel ¢ltration column in DB (Pharmacia Bio-
tech Inc.).
2.7. Phosphorylase a phosphatase assay
The phosphorylase a phosphatase assay was performed as previ-
ously described [11], except that gel ¢ltration was used to remove
free [Q-32P]ATP from the labeled phosphorylase a. Protamine (Sigma,
St. Louis, MO) was added at a ¢nal concentration of 10 Wg/ml to
increase PP2A activity. Bovine serum albumin was added at a ¢nal
concentration of 10 Wg/ml to facilitate protein precipitation after the
dephosphorylation reaction. The percentage dephosphorylation was
calculated as (cpm from sample incubation3cpm from control bu¡er
incubation):cpm from the added phosphorylase aU100%. Samples
were diluted until they dephosphorylated 940% of the substrates.
2.8. Assay of cdc25 dephosphorylating activity
Recombinant Xenopus cdc25, fused as its N-terminus to glutathione
S-transferase (GST-cdc25), was produced from Escherichia coli TG-1
cells harboring the expressing vector GEX-KG-cdc25 (a gift of A.R.
Nebreda and T. Hunt). The expression of GST-cdc25 was induced
with 0.08 mM isopropyl L-D-thiogalactopyranoside (IPTG, Boeh-
ringer Mannheim, Indianapolis, IN) overnight at 22‡C when the bac-
teria grew to OD600 0.8^1.0. Isolation of GST-cdc25 was done by
a⁄nity absorption of the induced cell lysates with glutathione agarose
(Sigma) in the presence of 10 mM DTT, 0.1 mM PMSF and 0.1 mg/
ml of each protease inhibitor (leupeptin, pepstatin A, and chymosta-
tin, Boehringer Mannheim). The washed beads were stored at 370‡C
for future use as immobilized GST-cdc25.
For measurement of dephosphorylation of cdc25 by MPM-2 immu-
noblotting, GST-cdc25 was phosphorylated by incubation of the im-
mobilized GST-cdc25 (0.2 Wg/Wl) with 1/3 volume MEE diluted 1:1
with EB containing 20 mM NaF, 1 mM DTT, 5 mM ATP and 0.5
WM OA at RT for 1 h. After the beads were washed three times with
WB and rinsed two times with XB containing 1 mM DTT, 10 Wl of
the phosphorylated GST-cdc25 were incubated with 30 Wl sample or
XB at RT for 30 min. The reaction was stopped by addition of SDS-
PAGE sample bu¡er. The proteins were then separated by 12.5%
SDS-PAGE, transblotted onto nitrocellulose and immunoblotted
with MPM-2.
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For measurement of dephosphorylation of cdc25 by 32P removal,
the immobilized GST-cdc25 was 32P-labeled by incubation with 1/3
volume MEE containing 2 WCi/Wl [32P]ATP and 2 mM ATP. After the
beads were washed as described above, the labeled GST-cdc25 was
eluted with 10 mM glutathione in XB. The free GST-cdc25 (2 Wg/10
Wl) was then incubated with 30 Wl sample from Superose 6 fractions at
RT for 30 min. The proteins were separated by 12.5% SDS-PAGE
and the gel was subjected to autoradiography.
2.9. Assay of dephosphorylation of GST-MPM2
GST-MPM2 immobilized onto glutathione agarose was prepared as
previously described [12]. The beads, which contained V0.2 Wg/Wl
GST-MPM2, were phosphorylated by MEE as described for phos-
phorylation of GST-cdc25. After the beads were washed three times
with WB and rinsed twice with XB, 10 Wl beads were incubated with
30 Wl of 1:20 diluted IOE at RT for 0^60 min. The proteins were then
eluted, separated by SDS-PAGE and immunoblotted with MPM-2.
3. Results
3.1. Development of an ELISA-based assay that measures
MPM-2 epitope phosphatase activity
The design of the ELISA-based assay to measure the
MPM-2 epitope phosphatase was based on the principle
that the recognition of MPM-2 antigens by the antibody
MPM-2 is phosphorylation-dependent [1]. Thus dephospho-
rylation of the MPM-2 epitope on MPM-2 antigens by a
phosphatase activity should result in a reduction of their re-
activity to the MPM-2 antibody (MPM-2 reactivity). The sub-
strates used for the assay were total proteins extracted from
M phase-arrested Xenopus eggs (MEE), which presumably
contained most, if not all, of the MPM-2 antigens in Xenopus
laevis [13]. MEE was coated on 96-well microtiter plates and
candidate phosphatase samples were added for the dephos-
phorylation reaction. After the plates were washed, ELISA
was used to quantitate the MPM-2 reactivity of the substrates.
Presumably, immobilization of MEE had disabled proteins in
MEE which might interfere with dephosphorylation of the
MPM-2 epitope. The bu¡er used in the assay contained 15
mM Mg2 and 0.3 mM Ca2, allowing detection of all four
major types of serine/threonine protein phosphatases [14].
To establish the validity of the assay, we ¢rst con¢rmed the
speci¢city of the detection of the phosphorylated MPM-2 epi-
tope by ELISA. It was previously shown that proteins ex-
tracted from interphase-arrested Xenopus oocytes (IOE) and
MEE contained unphosphorylated and phosphorylated
MPM-2 antigens respectively [13]. Thus, IOE and MEE
were immobilized on the same microtiter plate and their
MPM-2 reactivities were measured by ELISA. As shown in
Fig. 1A, the ELISA detected a 20-fold higher MPM-2 reac-
tivity in MEE relative to IOE; both extracts showed little
reactivity to the control antibody, RDA-1, which recognizes
a nuclear protein throughout the cell cycle. These results dem-
onstrated that the ELISA speci¢cally detected the phosphory-
lated MPM-2 epitope.
We next determined the ability of IOE to decrease the
MPM-2 reactivity in the substrates. IOE was chosen as a
possible source of MPM-2 epitope phosphatase activity be-
cause extracts made from interphase-arrested cells that lack
signi¢cant levels of phosphorylated MPM-2 antigens should
contain high levels of MPM-2 epitope phosphatase activity.
The substrates were ¢rst incubated with 1:20 diluted IOE at
either RT or 37‡C for 30 min. The 30 min incubation with
1:20 diluted IOE reduced the substrate MPM-2 reactivity by
30^40% at RT and by 40^50% at 37‡C (data not shown).
Substrates were then incubated at 37‡C for 30 min with
1:20 diluted IOE that had been preincubated at 4‡C, 37‡C,
50‡C or 65‡C for 30 min. Data presented in Fig. 1B show that
while the incubation with IOE that had been preincubated at
950‡C signi¢cantly reduced the substrate MPM-2 reactivity
as compared to the bu¡er control, the incubation with IOE
that had been preincubated at 65‡C did not decrease the sub-
strate MPM-2 reactivity. To determine the kinetics of the
IOE-induced reduction in the MPM-2 reactivity, the sub-
strates were incubated with 1:20 diluted IOE at 37‡C for 0^
4.5 h. The data in Fig. 2A show that the rate of the reduction
in the substrate MPM-2 reactivity was almost linear for the
¢rst 30 min, and progressively decreased thereafter. To deter-
mine the concentration dependency of the reaction, the sub-
strates were incubated with serially diluted IOE (1:2.5^
1:1280) at 37‡C for 30 min. The reduction in MPM-2 reac-
tivity was plotted as a function of concentration of IOE (Fig.
2B). For convenience, the concentration of undiluted IOE
which contained 10 mg/ml of protein was de¢ned as 100%.
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Fig. 1. Measurement of MPM-2 reactivity by ELISA. A: Individual
wells of a microtiter plate were coated with either MEE or IOE.
The immobilized proteins were then measured for their reactivity to
either MPM-2 or control antibody RDA-1 by ELISA, which was
indicated by absorbance at 405 nm. B: MEE immobilized on a mi-
crotiter plate was incubated for 30 min at 37‡C with either control
bu¡er or 1:20 diluted IOE that had been preincubated at 4‡C,
37‡C, 50‡C, or 65‡C for 30 min. The MEE on the plate was then
measured for MPM-2 reactivity by ELISA.
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Only at IOE concentrations of 92.5% of the original concen-
tration (or v1:40 dilution) was the concentration of IOE
proportional to the reduction in the substrate MPM-2 reac-
tivity. Taken together, these results demonstrated that this
assay detected an enzymatic activity in IOE that decreased
the MPM-2 reactivity of the substrates.
Four experiments were performed to con¢rm that the en-
zyme in IOE that decreased the MPM-2 reactivity in the sub-
strates was a phosphatase. We ¢rst examined whether the
ability of IOE to reduce the substrate MPM-2 reactivity was
sensitive to phosphatase inhibitors. The substrates were incu-
bated with 1:20 diluted IOE in the presence of either 2 WM
okadaic acid, which inhibits both PP1 and PP2A activities
[14], or 20 mM NaF, which inhibits a broad spectrum of
serine/threonine protein phosphatases. Both phosphatase in-
hibitors dramatically blocked the IOE-induced reduction in
the MPM-2 reactivity (Fig. 3A). Second, we examined
whether the reduction in the substrate MPM-2 reactivity
was accompanied by release of free phosphate. For this,
32P-labeled MPM-2 antigens were prepared (see Section 2),
coated onto microtiter plates and incubated with either con-
trol bu¡er or IOE of di¡erent dilutions at RT for 1 h. This
allowed measurement of loss of both the MPM-2 reactivity
and phosphate from the substrates. Data in Fig. 3B showed
that 32P was released from the substrates during incubation
with IOE which correlated with the reduction in the substrate
MPM-2 reactivity. Third, we examined whether there was
signi¢cant proteolysis during the incubation of the substrates
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Fig. 3. The reduction of the MPM-2 reactivity was due to dephos-
phorylation. A: MEE immobilized on a microtiter plate was incu-
bated at RT for 30 min with 1:20 diluted IOE alone, 1:20 diluted
IOE containing 2 WM OA, or 1:20 diluted IOE containing 20 mM
NaF. After the MPM-2 reactivity of the MEE was measured by
ELISA, the % reduction in the MPM-2 reactivity due to incubation
with each sample was calculated. B: 32P-labeled MPM-2 antigens
on a microtiter plate were incubated with IOE of indicated dilutions
at RT for 1 h. After the IOE sample and the ¢rst wash from each
well were recovered and combined, the relative amount of 32P in
each sample was measured in a scintillation counter. The proteins
remaining on the plate were measured for MPM-2 reactivity by
ELISA and the IOE-induced % reduction in the MPM-2 reactivity
was calculated.
Fig. 2. Time and concentration dependencies of the IOE-induced re-
duction in the MPM-2 reactivity. A: MEE immobilized on a micro-
titer plate was incubated with 1:20 diluted IOE at 37‡C for 0^8 h.
The MPM-2 reactivity of the MEE at each time point was meas-
ured by ELISA. The IOE-induced % reduction in the MPM-2 reac-
tivity was calculated as described in Section 2 and plotted as a func-
tion of the incubation time (h). B: MEE immobilized on a
microtiter plate was incubated at 37‡C for 30 min with IOE that
had been serially diluted 1^1280-fold. After the MPM-2 reactivity of
the MEE was measured by ELISA, the IOE-induced % reduction in
the MPM-2 reactivity was plotted as a function of the IOE concen-
tration.
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with IOE. For this, MEE proteins were immobilized on nylon
membrane and then incubated with IOE. The choice of nylon
membrane disks instead of the 96-well microtiter plates to
immobilize the substrates was simply due to the membrane’s
much higher protein binding capacity which was required for
this experiment. The immobilized proteins were then eluted,
separated by SDS-PAGE, and silver stained. As shown in Fig.
4A, similar pro¢les of polypeptides were recovered irrespective
of whether the substrates had been incubated with control
bu¡er or IOE. This indicated that there was no signi¢cant
proteolysis during the incubation. Finally, we addressed the
concern that the reduction in the substrate MPM-2 reactivity
observed by ELISA might be caused by masking of the
MPM-2 epitope by a binding protein in IOE such as Pin 1
[3]. For this, the substrates eluted from the membrane after
the incubation were separated by SDS-PAGE and immuno-
blotted with MPM-2, a procedure that should break any non-
covalent protein-protein interactions. As shown in Fig. 4B,
the IOE-treated substrates exhibited a signi¢cant decrease in
the entire spectrum of the MPM-2 antigens on the immuno-
blot. Collectively, these results indicated that this ELISA-
based assay measured a phosphatase activity in IOE that de-
phosphorylated the majority of the MPM-2 antigens.
3.2. Separation of the major MPM-2 epitope phosphatase
activity from the majority of PP1 and PP2A activity
To examine whether the MPM-2 epitope phosphatase ac-
tivity in IOE observed by the ELISA-based assay was due to a
speci¢c phosphatase, we fractionated IOE by sequential chro-
matography and followed both the MPM-2 epitope phospha-
tase activity and the phosphatase activity that dephosphoryl-
ates phosphorylase a which is a common substrate for PP1
and PP2A, the major serine/threonine protein phosphatases in
most eukaryotic cells [11]. In step 1, IOE was precipitated
with 45% ammonium sulfate. The precipitated proteins con-
tained v90% of the MPM-2 epitope dephosphorylating activ-
ity and v80% of the phosphorylase a phosphatase activity
(data not shown). In step 2, the 45% ammonium sulfate pre-
cipitate was loaded onto a Q-Sepharose column, which was
sequentially eluted with 0.2 M NaCl and 1.0 M NaCl. The
majority of the MPM-2 epitope and phosphorylase a phos-
phatase activities were recovered in the 0.2 M NaCl eluate
(data not shown). In step 3, the 0.2 M eluate from the Q-
Sepharose chromatography was loaded onto a heparin-Se-
pharose column which was sequentially eluted with 0.09 M
NaCl and 1.0 M NaCl. The £owthrough (FT) contained high
phosphorylase a phosphatase activity and low MPM-2 epi-
tope phosphatase activity, whereas the 0.09 M eluate (E1) con-
tained low phosphorylase a phosphatase activity and high
MPM-2 epitope phosphatase activity. In contrast, the 1.0 M
eluate (E2) contained low levels of both activities (Fig. 5A). In
step 4, E1 from the heparin-Sepharose chromatography was
fractionated by FPLC on a Superose 6 gel ¢ltration column.
The MPM-2 epitope phosphatase activity was eluted as a
distinct peak at an apparent molecular mass of V158 kDa,
which correlated with the low-level phosphorylase a phospha-
tase activity (data not shown). The recovered MPM-2 epitope
phosphatase activity was able to dephosphorylate the MPM-2
epitope on the majority of the MPM-2 antigens like crude
IOE (data not shown). In contrast, little MPM-2 epitope
phosphatase activity was recovered from fractionation of FT
through the Superose 6 column although high levels of phos-
phorylase a phosphatase activity were detected (data not
shown).
Since the results described above suggested that the major
MPM-2 epitope phosphatase activity was separated from the
majority of PP1 and PP2A activities, IOE and the three frac-
tions from the heparin-Sepharose chromatography were im-
munoblotted with commercial anti-human PP1 and PP2A
antibodies which work across species. Immunoblots with
anti-PP1 antibodies showed that IOE contained a readily de-
tectable polypeptide of the expected size whereas none of the
three fractions contained signi¢cant levels of this polypeptide
(Fig. 5B). This indicated that most if not all of PP1 protein
had been removed prior to this step and thus could not ac-
count for the detected MPM-2 epitope and phosphorylase a
phosphatase activities. Immunoblots with anti-PP2A antibod-
ies showed that both IOE and FT contained a strong poly-
peptide of the expected size, whereas E1 and E2 contained
much less and little of this polypeptide respectively (Fig.
5B), indicating that the recovered phosphorylase a phospha-
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Table 1
Puri¢cation of MPM-2 epitope phsophatase in Xenopus oocytes
Step Total protein (mg) Total activity (units) Speci¢c activity (units/mg) Yield (%) Puri¢cation (fold)
Oocyte extract 48.15 820 17.03 100 1
Ammonium sulfate 20.05 735 36.66 89.6 2.15
Q-Sepharose 11.3 697.5 61.88 85.1 3.62
Heparin-Sepharose 1.78 612.5 344.1 74.7 20.2
Superose 6 0.113 110.4 977.0 13.5 57.4
Fig. 4. Analysis of eluted proteins. Five nylon membrane disks (0.5
mm in diameter) were soaked in 1:80-diluted MEE at 4‡C for 2 h
and then rinsed four times with TBST. The coated disks were then
incubated with bu¡er (lane B) or 1:20 diluted IOE (lane IOE) at
37‡C for 30 min. After the discs were washed again four times with
TBST, the proteins were eluted by incubation with 3% SDS at 22‡C
for 2 h and then at 95‡C for 5 min. A: The eluted proteins were
separated by 12.5% SDS-PAGE and silver stained. B: The eluted
proteins were separated by 12.5% SDS-PAGE and immunoblotted
with MPM-2.
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tase activity was mostly due to PP2A. Although further stud-
ies are required to determine the relationship between the
major MPM-2 epitope phosphatase activity and the minor
PP2A activity in E1, this result indicated that the major
MPM-2 epitope phosphatase activity was separated at least
from the majority of PP2A activity.
Coomassie blue staining of the SDS-PAGE separated pro-
teins from the last step of the fractionation showed that fur-
ther chromatography was required in order to identify the
putative polypeptides that comprise this phosphatase (data
not shown). Table 1 summarizes recoveries from each step
of the fractionation in a typical puri¢cation. For quantitation,
one unit of the MPM-2 epitope dephosphorylating activity
was arbitrarily de¢ned as the amount of enzyme that caused
a 20% reduction in the MPM-2 reactivity. After the four-step
fractionation procedure, approximately 13% of the starting
MPM-2 epitope phosphatase activity was recovered and a
57-fold enrichment achieved. Recovery of the MPM-2 epitope
phosphatase activity was nearly quantitative until the last
step, FPLC on Superose 6. In this step, the overall recovery
of protein was low as well, suggesting that the loss of MPM-2
epitope phosphatase activity was non-speci¢c.
Overall, these results demonstrate that there is a speci¢c
phosphatase activity in IOE that preferentially dephosphoryl-
ates the MPM-2 epitope on multiple MPM-2 antigens. This
phosphatase activity is separated from the majority of PP1
and PP2A activities.
3.3. The major MPM-2 epitope phosphatase activity copuri¢ed
with one of the two major cdc25 dephosphorylating
activities
Since a phosphatase assay which uses a de¢ned substrate
would be less complicated and more e⁄cient than the ELISA-
based assay, we next explored the possibility that the major
MPM-2 epitope phosphatase activity in IOE could be assayed
by using a single puri¢ed MPM-2 antigen as the substrate.
For this, GST-cdc25, a fusion protein between GST and
cdc25, a known MPM-2 antigen [7], was tested. Non-treated
GST-cdc25 migrated on SDS-PAGE as two major bands of
100 kDa and 76 kDa which represented the full-length and a
cleaved version of GST-cdc25. Both bands migrated more
slowly and became MPM-2 reactive upon phosphorylation
with MEE while GST alone did not acquired any MPM-2
reactivity (data not shown). The phosphorylated and repuri-
¢ed GST-cdc25 was incubated with various chromatographic
fractions from the four-step puri¢cation scheme and then sub-
jected to SDS-PAGE and MPM-2 immunoblotting. This
method measured the speci¢c dephosphorylation of the
MPM-2 epitope on cdc25. Samples were also separated by
SDS-PAGE and stained with Coomassie blue to check for
any degradation of the GST-cdc25. No degradation of
GST-cdc25 was observed (data not shown).
In the initial 45% ammonium sulfate precipitation, the
cdc25 dephosphorylating activity was recovered mostly in
the precipitated proteins like the recovered MPM-2 epitope
phosphatase activity (data not shown). In step 2, the Q-Se-
pharose chromatography of the 45% ammonium sulfate pre-
cipitate, the cdc25 dephosphorylating activity was mostly de-
tected in the 0.2 M NaCl eluate, again like the recovered
MPM-2 epitope phosphatase activity (data not shown). How-
ever, in step 3, the heparin-Sepharose chromatography of the
0.2 M eluate from the Q-Sepharose chromatography, a high
cdc25 dephosphorylating activity was recovered in both FT
and E1 (Fig. 5C), whereas a high MPM-2 epitope phospha-
tase activity was detected mostly in E1 (Fig. 5A). In step 4,
the Superose 6 chromatography of E1, there was a good cor-
relation between the MPM-2 epitope phosphatase activity and
the dephosphorylation of GST-cdc25. The fractions 31^33
which contained the highest MPM-2 epitope phosphatase ac-
tivity removed most of the MPM-2 reactivity from GST-cdc25
(Fig. 6A,B). These results suggest that there are two major
phosphatase activities in IOE that dephosphorylate the MPM-
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Fig. 5. Fractionation of Xenopus oocyte extracts. IOE was sequen-
tially fractionated by 45% ammonium sulfate precipitation. Q-Se-
pharose chromatography and heparin-Sepharose chromatography as
described in Section 2. The £owthrough (FT), the 0.09 M NaCl elu-
ate (E1), and the 1.0 M NaCl eluate (E2) from the heparin-Sepha-
rose chromatography were adjusted to same volume as the starting
IOE. A: The three fractions were diluted 1:20 and measured for the
MPM-2 epitope phosphatase activity by incubation for 30 min at
37‡C. The samples were also measured for phosphorylase a phos-
phatase activity as described in Section 2. B: Aliquots of 20 Wl from
the starting IOE and each of the three fractions were separated by
12.5% SDS-PAGE and immunoblotted with anti-PP1 or anti-PP2A
antibody. C: Phosphorylated GST-cdc25 (2 Wg/10 Wl) was incubated
with 30 Wl of either control bu¡er (CB) or 1:20 diluted IOE, FT,
E1 and E2 at RT for 1 h. Proteins were separated by 12.5% SDS-
PAGE and immunoblotted with MPM-2. The arrows indicated the
positions of the unphosphorylated 100 kDa and 76 kDa GST-
cdc25.
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2 epitope on GST-cdc25, and that only one of them copuri¢ed
with the major MPM-2 epitope phosphatase activity.
cdc25 is known to be phosphorylated on more than seven
sites [15,16], however, the percentage of them that are MPM-2
epitopes has not been determined. To examine whether the
major MPM-2 epitope phosphatase activity dephosphorylated
cdc25 on most of the phosphorylation sites, the fractions from
Superose 6 were incubated with 32P-labeled GST-cdc25 and
the total dephosphorylation of GST-cdc25 was measured by
SDS-PAGE and autoradiography. The fractions 31^33 that
contained the highest MPM-2 epitope phosphatase activity
removed most of the 32P from the labeled GST-cdc25 (Fig.
6C), indicating that most of the phosphorylation sites on
GST-cdc25 could be e⁄ciently dephosphorylated by the major
MPM-2 epitope phosphatase activity.
Since FT from the heparin-Sepharose chromatography con-
tained high levels of both PP2A protein and phosphorylase a
phosphatase activity, it seemed likely that the cdc25 dephos-
phorylating activity in it was due to the major PP2A activity.
To test this, FT was fractionated by FPLC on Superose 6 and
the fractions were both assayed for cdc25 and phosphorylase
a dephosphorylating activities and immunoblotted with anti-
PP2A antibody. The cdc25 dephosphorylating activity copuri-
¢ed with both phosphorylase a phosphatase activity and
PP2A protein (data not shown), supporting the possibility
that the one of the cdc25 dephosphorylating activities was
due to the major species of PP2A.
3.4. The major MPM-2 epitope dephosphorylating activity did
not dephosphorylate the MPM-2 epitope in the
GST-MPM2 fusion protein
Since the results described above indicated that cdc25 is not
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Fig. 6. Cdc25 dephosphorylating activity during Superose 6 chromatography. A: Fractions 22^40 from the Superose 6 gel ¢ltration of the E1
from the heparin-Sepharose chromatography were 1:5 diluted and measured for MPM-2 epitope phosphatase activity by the ELISA-based as-
say for 30 min at RT. The numbered vertical arrows indicate the positions of the standard proteins, (1) thyroglobulin (670 kDa), (2) bovine
IgG (158 kDa), (3) chicken ovalbumin (44 kDa), and (4) equine myoglobin (17 kDa). B: Phosphorylated GST-cdc25 (2 Wg/10 Wl) was incubated
with 30 Wl aliquots from the same fractions at RT for 1 h. The samples were separated by SDS-PAGE and immunoblotted with MPM-2. C:
32P-labeled GST-cdc25 (2 Wg/10 Wl) were incubated with 30 Wl aliquots from the same fractions at RT for 30 min. The samples were separated
by SDS-PAGE and subjected to autoradiography.
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a speci¢c substrate for the major MPM-2 epitope phosphatase
activity, we explored the possibility that the MPM-2 epitope
consensus sequence could be used as the speci¢c substrate to
assay the major MPM-2 epitope phosphatase activity. For
this, GST-MPM2, a fusion protein between GST and a 19-
residue peptide that contained two representative MPM-2
epitope sequences [12], was used as the substrate for the phos-
phatase assay. It was reported that GST-MPM2 became
MPM-2 reactive upon phosphorylation with MEE and all
the phosphorylation was on the MPM-2 epitope. The phos-
phorylated GST-MPM2 could be both immunoprecipitated
with MPM-2 and dephosphorylated by potato acid phospha-
tase (data not shown), indicating that the phosphorylation site
was open for dephosphorylation.
GST-MPM2 was ¢rst incubated with 1:20 diluted IOE for
0^60 min. GST-cdc25 was incubated in parallel as a positive
control. Proteins were then separated by SDS-PAGE and im-
munoblotted with MPM-2. As shown in Fig. 7, the MPM-2
epitope on GST-cdc25 was quantitatively dephosphorylated
within 30 min whereas a signi¢cant portion of GST-MPM2
remained phosphorylated even after the 60 min incubation.
Similar results were obtained when 1:1 diluted IOE or parti-
ally puri¢ed MPM-2 epitope phosphatase activity was used
for dephosphorylation (data not shown). These results indi-
cated that the MPM-2 epitope on GST-MPM2 could not be
e⁄ciently dephosphorylated by the major MPM-2 epitope
phosphatase activity in IOE.
4. Discussion
Protein dephosphorylation is required for cells to exit from
mitosis and remain in interphase during eukaryotic cell cycles
[17,18]. MPM-2 antigens comprise one of the major families
of mitotic phosphoproteins that are simultaneously dephos-
phorylated from the onset of anaphase and remain dephos-
phorylated throughout interphase [1]. In this ¢rst attempt to
characterize the phosphatase that is responsible for the de-
phosphorylation of MPM-2 antigens (MPM-2 epitope phos-
phatase), we tried to develop a speci¢c assay to measure its
activity. To this end, three approaches were used. The ¢rst
was an ELISA-based assay, which measured the phosphatase-
induced reduction in the MPM-2 reactivity of crude M phase
lysates. Using this method to follow the phosphatase activity
during sequential chromatography of Xenopus oocyte extracts,
one predominant phosphatase activity was detected which was
separated from the majority of PP1 and PP2A activities. This
phosphatase activity dephosphorylated the MPM-2 epitope
on the majority of the MPM-2 antigens. The second method
measured dephosphorylation of GST-cdc25, a single puri¢ed
MPM-2 antigen. Using this assay, two major phosphatase
activities were detected from the sequential chromatography,
one that copuri¢ed with the major MPM-2 epitope phospha-
tase activity, and the other that copuri¢ed with the major
PP2A activity. The third method measured dephosphorylation
of the MPM-2 epitope consensus sequences in GST-MPM2, a
fusion protein between GST and a 19-residue peptide that
contained two representative MPM-2 epitope sequences. The
MPM-2 epitopes in the fusion protein could not be e⁄ciently
dephosphorylated by the major MPM-2 epitope phosphatase
activity in Xenopus oocyte extracts.
Since the ELISA-based assay e⁄ciently detects the major
phosphatase activity that dephosphorylates the MPM-2 epi-
tope on multiple MPM-2 antigens but not the majority of PP1
and PP2A activities under the same conditions, this assay
appears to be both e⁄cient and selective for the MPM-2 epi-
tope phosphatase activity. Most protein serine/threonine pro-
tein phosphatases have broad substrate speci¢cities when as-
sayed in vitro. Three unique features might account for the
preferential detection of the MPM-2 epitope phosphatase ac-
tivity by the ELISA-based assay. First, the M phase cell ly-
sates contain not only high levels of the entire spectrum of
phosphorylated MPM-2 antigens which are the substrates for
the MPM-2 epitope phosphatase, but also substrates for other
protein phosphatases. Thus, the non-speci¢c dephosphoryla-
tion of the MPM-2 epitope by other protein phosphatases
may be decreased. Second, since the substrates contain multi-
ple MPM-2 antigens, even if a phosphatase is able to dephos-
phorylate certain MPM-2 antigens non-speci¢cally, its activity
should be much less than that of the phosphatase that dephos-
phorylates many or all MPM-2 antigens. Third, dephospho-
rylation of sites other than MPM-2 epitopes are not measured
by the ELISA-based assay. Because of the speci¢city of the
assay, there is a good possibility that the major phosphatase
activity in Xenopus oocyte extracts detected by this assay rep-
resents a physiological MPM-2 epitope phosphatase. To con-
¢rm this possibility, the ability of this phosphatase activity to
dephosphorylate multiple MPM-2 antigens will be examined
in vivo in future studies.
The cdc25 dephosphorylation method e⁄ciently detected
both the major MPM-2 epitope phosphatase activity and
the major PP2A activity. Dephosphorylation of cdc25 by
PP2A was also suggested by others previously [19]. Although
it is possible that both the major MPM-2 epitope phosphatase
activity and the major PP2A activity are important for de-
phosphorylation of the MPM-2 epitope on cdc25 in vivo, it
is unlikely that the major PP2A activity which did not dephos-
phorylate the MPM-2 epitope on multiple MPM-2 antigens
e⁄ciently in vitro is important for the dephosphorylation of
many MPM-2 antigens in vivo. Thus, the use of the cdc25
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Fig. 7. Comparison of dephosphorylations of GST-cdc25 and GST-
MPM2 by IOE. Phosphorylated GST-cdc25 (A) or GST-MPM2 (B)
was incubated with 1:20 diluted IOE at RT for the indicated
lengths of time. The proteins were separated by 12.5% SDS-PAGE
and immunoblotted with MPM-2. The arrows in A indicate the po-
sitions of 100 kDa and 76 kDa unphosphorylated GST-cdc25. The
arrow in B indicates the position of GST-MPM2.
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dephosphorylation method would generate misleading infor-
mation if used alone to assay the MPM-2 epitope phosphatase
activity in crude samples, although it would be an excellent
method for analysis of puri¢ed MPM-2 epitope phosphatase
activity.
The ¢nding that the MPM-2 epitope in GST-MPM2 could
not be dephosphorylated by the major MPM-2 epitope phos-
phatase activity in IOE e⁄ciently suggests that the MPM-2
epitope phosphatase requires more structural information
than the deduced MPM-2 epitope sequence for the recogni-
tion and dephosphorylation by the MPM-2 epitope phospha-
tase. It was recently found that the MPM-2 epitope in GST-
MPM2 was not su⁄cient for the recognition and the phos-
phorylation by the major kinase activity in MEE that phos-
phorylates the MPM-2 epitope on multiple MPM-2 antigens
[12]. On the other hand, the MPM-2 epitope sequences were
su⁄cient for the recognition by the prolyl isomerase Pin 1, a
mitotic regulator, in a phosphorylation dependent manner [3].
This suggests that MPM-2 epitope may have two functions.
First, it acts in concert with an additional domain(s) to direct
the MPM-2 kinase and phosphatase. Second, once phos-
phorylated, it is an acceptor site for the regulatory protein
Pin 1.
Genetic studies in Aspergillus showed that mutation of PP1
catalytic subunit inhibited both the completion of anaphase
and dephosphorylation of the MPM-2 antigens [4]. This raises
the possibility that PP1 is the phosphatase that dephospho-
rylates the MPM-2 antigens. However, our results show that
the major MPM-2 epitope phosphatase activity in interphase-
arrested Xenopus oocyte extracts is separated from most or all
of PP1 activity. This suggests that either a speci¢c and tran-
sient PP1 activity dephosphorylates the MPM-2 antigens at
the exit from mitosis or PP1 is not directly involved in the
dephosphorylation of MPM-2 antigens.
Previous studies showed that ABC, the predominant species
of PP2A, was the major phosphatase activity that dephos-
phorylated mitotic cdc2 kinase substrates [20^22]. Since the
major MPM-2 epitope dephosphorylating activity was sepa-
rated from the major PP2A activity, it appears that the major
MPM-2 epitope phosphatase activity detected by the ELISA-
based method is di¡erent from the phosphatase activity that
dephosphorylates the cdc2 kinase substrates. Supporting this
possibility, while the MPM-2 epitope phosphatase activity was
not suppressed in undiluted Xenopus oocyte extracts (Fig. 2B),
the overall PP2A activity is strongly suppressed in concen-
trated cell extracts [23]. The apparent di¡erence between the
two phosphatase activities suggest that MPM-2 antigens and
cdc2 kinase substrates are dephosphorylated either by di¡er-
ent phosphatases or by di¡erent subtypes of PP2A.
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